Seborrheic Keratosis Can a Gel Clear It? The Real Evidence

Key wellness / self-care / productivity takeaways (from the subtitles)

• Don’t self-treat without confirming the diagnosis

  • Not every rough brown spot is seborrheic keratosis.
  • If a spot is changing, growing, darkening, bleeding, itching, or looks different from your other spots: get it assessed by a trained clinician first.
  • Never apply a “DIY” treatment to an unassessed lesion—confirm the diagnosis, then treat.

• Evidence-based home treatment option (diclofenac gel)

  • The video discusses diclofenac gel (Voltaren in some countries) as an at-home option supported by clinical trial evidence for seborrheic keratosis.
  • Key points:
    • No freezing/procedures involved.
    • It’s not a miracle, but studies show supportive results.

• What the evidence suggests about strength

  • 3% diclofenac gel
    • Described as having the strongest evidence.
    • Typically prescription-only and licensed for actinic keratosis, not seborrheic keratosis (off-label use when prescribed).
    • In a larger study: nearly 7 in 10 people became completely clear or nearly clear; the dummy gel group: none cleared.
  • 1% diclofenac gel
    • Often available OTC.
    • Evidence is less strong, but the study still showed real shrinkage.

• Approach if you want to try it

  • Ask your GP or skin specialist at your appointment about diclofenac gel for seborrheic keratosis (especially if it’s bothering you).
  • If you can’t access the 3% version, the video suggests considering 1% OTC—but only after diagnosis is confirmed.

• Important comparison nuance

  • In one trial, studies compared diclofenac to another anti-inflammatory (ibuprofen gel); ibuprofen didn’t work, while diclofenac did—suggesting a diclofenac-specific effect, not just “anti-inflammatory” in general.
  • The video also notes a gap: no head-to-head comparison between diclofenac strengths (e.g., 1% vs 3%).

Presenters / sources

• Presenter: Dr. Finbarr (also referred to as Dr. Phenbar in the subtitles) — GP with a special interest in dermatology/skin cancer; runs Dr. Finbarr’s Skin Clinic, Northern Ireland.
• Medical product referenced: Diclofenac gel (Voltaren)
• Other references mentioned:
  • Evidence from case report(s) and randomized trials
  • Systematic review (topical treatments with good-to-excellent results)
  • Actinic keratosis licensing context (diclofenac 3%)